/ /

CLINICAL

New eye drop assistant helps drive complianceAs ODs, we are fully aware of the challenge patient compliance with prescribed eye drops. To assuage the battle of compliance, eye drop manufacturers are assiduously working to devise drug delivery systems that reduce or eliminate patients’ engagement in the instillation of their prescribed therapy. But until ODs no longer use eye drops, drops remain our primary mode of drug delivery.
Glasses and contact lenses: Have they become a commodity?Sell the best thing you have going for you—you.
The changing dry eye dynamicTo understand how far we have come, you must remember where we started.
Aflibercept helps in ME patients with DR after cataract surgeryPatients with diabetic retinopathy have a high risk of developing macular edema after cataract surgery. Intravitreal injections of aflibercept might result in fewer patients developing macular edema in this patient population.
ALG-1001: Turning off the machinery of angiogenesisALG-1001 (Luminate, Allegro Ophthalmics) has a number of different mechanisms of action that benefit patients chronically treated with anti-vascular endothelial growth factor drugs and those who are treatment naïve.
AO imaging offers novel data for understanding retinal diseaseAdaptive optics (AO) is providing new insights about retinal structure and may help to identify potential areas for treatment of retinal diseases, said Mina Chung, MD.
Role of corticosteroids uncertain in AMD managementThere is no doubt that inflammation is a component of age-related macular degeneration (AMD), and yet the role of corticosteroid treatment in the management of eyes with AMD remains uncertain, said Marc de Smet, MD, PhD.
P.S. Use this cost-effective marketing tactic to increase end-of-year profitsWhen you do not have enough money or time, a well-worded post script can be your best friend. Whether you are the new doctor who doesn’t have a large database or the kind-hearted provider who accepts all those low-paying plans and really can’t afford the estimated 60 cents per unit cost of a fall postcard campaign, please consider adding a P.S. to emails and a red-ink P.S. to all patient-directed, routine postal pieces.
How novel anticoagulants compare with warfarin for intraocular bleedingHow do the newer anticoagulant medications compare with warfarin when it comes to the risk of intraocular bleeding? A meta-analysis published in JAMA Ophthalmology did a systematic review of phase 3 randomized trials looking at over 100,000 patients.
Engaging OCTA in glaucoma imaging
Engaging OCTA in glaucoma imagingA prospective, observational study found that eyes with mild POAG could be differentiated from pre-perimetric glaucomatous eyes, which also could be differentiated from normal eyes using OCTA-derived retinal vessel density measurements.